Abstract. Despite recent advances, the prognosis of relapsed osteosarcoma patients remains very poor. Application of high energy shock waves may change the tumour cell growth and increase the cytotoxic effect of in vivo and in vitro chemotherapeutic agents. We studied the effect of their association with doxorubicin or methotrexate on three in vitro osteosarcoma cell lines. The effect of these combinations on SJSA-1, MG-63 and HOS human osteosarcoma cell lines were evaluated through incubation with doxorubicin or methotrexate and high energy shock wave treatment with 1000 shots at 0.22 mJ/mm 2 and an evaluation of the cell number, cell proliferation and apoptosis at days 1, 3 and 6 from the start of treatment. The combination of high energy shock waves and doxorubicin induced a statistically significant advantage in terms of a decrease in cell number on the SJSA-1 and HOS cell lines, a decrease of cell proliferation on all three cell lines and an increase of apoptosis only on the SJSA-1 cell line. The combination of high energy shock waves with methotrexate induced a decrease of the cell number only in the SJSA-1 and in the HOS cell lines, of the cell proliferation in the SJSA-1 and in the MG-63 cell lines, and an increase of apoptosis only on the SJSA-1 cell line. In conclusion, these experiments show an interesting effect of high energy shock waves on osteosarcoma cell lines, which could lead to future studies of the in vivo effects of high energy shock waves in the murine model as well.
IntroductionOsteosarcoma (OS) is the most frequent bone tumour and is most common between the ages of 15 and 25. A high number of patients have a high-grade tumour, which prognosis has dramatically improved from 10-15% to 65-70% in the last 25 years, thanks to the use of adjuvant and neoadjuvant chemotherapy (1,2). Nevertheless, despite continuing scientific research into the treatment, the prognosis of the patients with OS in metastatic relapse, especially to bones (3), is still very poor; even with a recently concluded Italian and Scandinavian phase II protocol including high-dose chemotherapy the 3-year overall survival and the 3-year disease free-survival rates were only 20% and 12% respectively (4).The search of new treatments for improving the survival of the patients without increasing the collateral effects of the chemotherapy has led us to study new ways to increase the chemo-sensitivity of the OS cells.High energy shock waves (HESW) are routinely used in clinical practise in orthopaedic and in urology to treat a number of different diseases, such as urinary stones, non-unions of the bone fractures, tennis elbow, calcifying tendonitis, pseudoarthrosis and necrosis of the femoral head (5,6).In the past, many studies of HESW were conducted on different human and animal tumour cell lines, describing an alteration of the cell growth (7-11). The in vitro effects of shock waves are due to a suppression of cell proliferation correlated with an apoptotic cell death process; moreover, HESW treatment has been shown to cause a t...